PR, ER expression may predict outcomes in certain ovarian cancers + commentary (repost)

 Hematology Oncology

"....The analysis included 1,742 women with high-grade serous disease, 110 with low-grade serous cancer, 207 with mucinous disease, 484 with cancer of the endometrioid, and 390 with clear-cell disease.
Researchers observed an association between PR expression and increased disease-specific survival among women with endometrial disease (log rank P<.0001) and high-grade serous disease (log rank P=.0006). Researchers also observed an association between ER expression and improved disease-specific survival (log rank P<.0001).
Researchers did not observe significant associations for mucinous, clear-cell or low-grade serious disease.....